It has long been known that cooling can increase survival chances after critical illnesses, such as cardiac arrest, by reducing the risk of brain damage caused by oxygen deprivation.
QuickCool AB offers a unique, portable, quick-to-apply brain and body cooling system with a delivery method that does not impede medical procedures. The cooling process is rapidly initiated via the nasal cavity, giving medical staff access to the rest of the body for examinations and treatment.
The QuickCool® SYSTEM is an easy-to-use, portable solution for temperature management at 36°C – a temperature recommended for cooling cardiac arrest patients.
Targeted Temperature Management (TTM), is an active therapy to achieve and maintain a specific body temperature in a patient for a specific period, in an effort to improve health outcomes.
The QuickCool Advisory Board was founded in February 2016 to serve as a company-wide guidance forum for concepts and ideas during the development process.
Here you will find the latest corporate news and monthly newsletters.
Do you wish to know more about our unique cooling system? Contact us today.
Learn more about QuickCool's exciting story.
